Skip to content
OpenCapital
Get started

Travere Therapeutics, Inc. TVTX Shares (Basic)

Shares (Basic) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
254.1M-1.1%
LQD
Liquidia CorporationLQDA
88M+3.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
Arrowhead Research logo
Arrowhead ResearchARWR
142.4M+6.8%
PTC Therapeutics logo
PTC TherapeuticsPTCT
82.5M+5.6%
Scholar Rock logo
Scholar RockSRRK
127.3M+13.8%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K—
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%
Enterprise value$5.07B+65.5%
P/S9.6×-1.3×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s shares (basic)?
Travere Therapeutics, Inc. (TVTX) reported shares (basic) of 91.9M in Q1 2026.
How has Travere Therapeutics, Inc.'s shares (basic) changed year-over-year?
Travere Therapeutics, Inc.'s shares (basic) increased by 4.0% year-over-year, from 88.4M to 91.9M.
What is the long-term trend for Travere Therapeutics, Inc.'s shares (basic)?
Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s shares (basic) has grown at a 10.6% compound annual growth rate (CAGR), from 237.5M to 355.7M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.